304 related articles for article (PubMed ID: 28544818)
1. Ubiquitination in melanoma pathogenesis and treatment.
Ma J; Guo W; Li C
Cancer Med; 2017 Jun; 6(6):1362-1377. PubMed ID: 28544818
[TBL] [Abstract][Full Text] [Related]
2. An Update on the Role of Ubiquitination in Melanoma Development and Therapies.
Soysouvanh F; Giuliano S; Habel N; El-Hachem N; Pisibon C; Bertolotto C; Ballotti R
J Clin Med; 2021 Mar; 10(5):. PubMed ID: 33800394
[TBL] [Abstract][Full Text] [Related]
3. Unveil the mysterious mask of cytokine-based immunotherapy for melanoma.
Xu DH; Zhu Z; Xiao H; Wakefield MR; Bai Q; Nicholl MB; Ding VA; Fang Y
Cancer Lett; 2017 May; 394():43-51. PubMed ID: 28254411
[TBL] [Abstract][Full Text] [Related]
4. Growth and progression of melanoma and non-melanoma skin cancers regulated by ubiquitination.
Nakayama K
Pigment Cell Melanoma Res; 2010 Jun; 23(3):338-51. PubMed ID: 20230483
[TBL] [Abstract][Full Text] [Related]
5. Signaling and Immune Regulation in Melanoma Development and Responses to Therapy.
Lin WM; Fisher DE
Annu Rev Pathol; 2017 Jan; 12():75-102. PubMed ID: 27959628
[TBL] [Abstract][Full Text] [Related]
6. Emerging Role of Deubiquitinating Enzymes (DUBs) in Melanoma Pathogenesis.
Ohanna M; Biber P; Deckert M
Cancers (Basel); 2022 Jul; 14(14):. PubMed ID: 35884430
[TBL] [Abstract][Full Text] [Related]
7. New drug targets in metastatic melanoma.
Homet B; Ribas A
J Pathol; 2014 Jan; 232(2):134-41. PubMed ID: 24027077
[TBL] [Abstract][Full Text] [Related]
8. Ubiquitination-proteasome system: A new player in the pathogenesis of psoriasis and clinical implications.
Yang L; Guo W; Zhang S; Wang G
J Dermatol Sci; 2018 Mar; 89(3):219-225. PubMed ID: 29279285
[TBL] [Abstract][Full Text] [Related]
9. Sphingosine metabolism as a therapeutic target in cutaneous melanoma.
Dany M
Transl Res; 2017 Jul; 185():1-12. PubMed ID: 28528915
[TBL] [Abstract][Full Text] [Related]
10. Immune Responses to BRAF-Targeted Therapy in Melanoma: Is Targeted Therapy Immunotherapy?
Kelley MC
Crit Rev Oncog; 2016; 21(1-2):83-91. PubMed ID: 27481005
[TBL] [Abstract][Full Text] [Related]
11. Understanding melanoma signaling networks as the basis for molecular targeted therapy.
Smalley KS
J Invest Dermatol; 2010 Jan; 130(1):28-37. PubMed ID: 19571822
[TBL] [Abstract][Full Text] [Related]
12. E3 ubiquitin ligases as drug targets and prognostic biomarkers in melanoma.
Bielskienė K; Bagdonienė L; Mozūraitienė J; Kazbarienė B; Janulionis E
Medicina (Kaunas); 2015; 51(1):1-9. PubMed ID: 25744769
[TBL] [Abstract][Full Text] [Related]
13. STAT3 targeting by polyphenols: Novel therapeutic strategy for melanoma.
Momtaz S; Niaz K; Maqbool F; Abdollahi M; Rastrelli L; Nabavi SM
Biofactors; 2017 May; 43(3):347-370. PubMed ID: 27896891
[TBL] [Abstract][Full Text] [Related]
14. Integrating molecular biomarkers into current clinical management in melanoma.
Kudchadkar R; Gibney G; Sondak VK
Methods Mol Biol; 2014; 1102():27-42. PubMed ID: 24258972
[TBL] [Abstract][Full Text] [Related]
15. Translational Research in Cutaneous Melanoma: New Therapeutic Perspectives.
Marra A; Ferrone CR; Fusciello C; Scognamiglio G; Ferrone S; Pepe S; Perri F; Sabbatino F
Anticancer Agents Med Chem; 2018; 18(2):166-181. PubMed ID: 29256359
[TBL] [Abstract][Full Text] [Related]
16. Melanoma genetics: the other side.
Bis S; Tsao H
Clin Dermatol; 2013; 31(2):148-55. PubMed ID: 23438378
[TBL] [Abstract][Full Text] [Related]
17. Signal transduction in human cutaneous melanoma and target drugs.
Uzdensky AB; Demyanenko SV; Bibov MY
Curr Cancer Drug Targets; 2013 Oct; 13(8):843-66. PubMed ID: 23675881
[TBL] [Abstract][Full Text] [Related]
18. Repressing CD147 is a novel therapeutic strategy for malignant melanoma.
Hu X; Su J; Zhou Y; Xie X; Peng C; Yuan Z; Chen X
Oncotarget; 2017 Apr; 8(15):25806-25813. PubMed ID: 28445958
[TBL] [Abstract][Full Text] [Related]
19. Epigallocatechin-3-gallate(EGCG) suppresses melanoma cell growth and metastasis by targeting TRAF6 activity.
Zhang J; Lei Z; Huang Z; Zhang X; Zhou Y; Luo Z; Zeng W; Su J; Peng C; Chen X
Oncotarget; 2016 Nov; 7(48):79557-79571. PubMed ID: 27791197
[TBL] [Abstract][Full Text] [Related]
20. Anti-PD-1 therapy in melanoma.
Homet Moreno B; Parisi G; Robert L; Ribas A
Semin Oncol; 2015 Jun; 42(3):466-73. PubMed ID: 25965365
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
